Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hook-associated protein 2 (HAP2), also known as Generative cell-specific protein 1 (GCS1), is a highly conserved membrane protein essential for gamete fusion across diverse eukaryotic lineages, including plants, protists, and invertebrates (UniProt Q8I4V7). In the context of human health, HAP2 is a primary target for transmission-blocking vaccines (TBVs) against malaria-causing parasites like Plasmodium falciparum (Angrisano et al., 2017, BMC Biology). Structurally, HAP2 is classified as a Class II viral-like fusogen, sharing significant homology with fusion proteins found in viruses such as Dengue and Zika (Fedry et al., 2017, Cell). It is specifically expressed on the surface of male gametes, where it facilitates the merger of the male and female plasma membranes during fertilization in the mosquito midgut (Pinello et al., 2017, JBC). Therapeutic strategies focus on inducing antibodies that bind to the extracellular domain of HAP2, thereby neutralizing the parasite's ability to reproduce sexually and preventing the spread of infection to new hosts. Because HAP2 is absent in mammals, it represents a highly specific target with a low risk of off-target effects in humans.
Inhibition of gamete fusion by binding to the extracellular domain of HAP2 on male gametes, preventing the merger of male and female plasma membranes during the sexual stage of the parasite life cycle (Fedry et al., 2017, Cell).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hook-associated protein 2 (HAP2) (HAP2).